Health technology funding decision-making processes around the world: the same, yet different
- PMID: 21568357
- DOI: 10.2165/11586420-000000000-00000
Health technology funding decision-making processes around the world: the same, yet different
Abstract
All healthcare systems routinely make resource allocation decisions that trade off potential health gains to different patient populations. However, when such trade-offs relate to the introduction of new, promising health technologies, perceived 'winners' and 'losers' are more apparent. In recent years, public scrutiny over such decisions has intensified, raising the need to better understand how they are currently made and how they might be improved. The objective of this paper is to critically review and compare current processes for making health technology funding decisions at the regional, state/provincial and national level in 20 countries. A comprehensive search for published, peer-reviewed and grey literature describing actual national, state/provincial and regional/institutional technology decision-making processes was conducted. Information was extracted by two independent reviewers and tabulated to facilitate qualitative comparative analyses. To identify strengths and weaknesses of processes identified, websites of corresponding organizations were searched for commissioned reviews/evaluations, which were subsequently analysed using standard qualitative methods. A total of 21 national, four provincial/state and six regional/institutional-level processes were found. Although information on each one varied, they could be grouped into four sequential categories: (i) identification of the decision problem; (ii) information inputs; (iii) elements of the decision-making process; and (iv) public accountability and decision implementation. While information requirements of all processes appeared substantial and decision-making factors comprehensive, the way in which they were utilized was often unclear, as were approaches used to incorporate social values or equity arguments into decisions. A comprehensive inventory of approaches to implementing the four main components of all technology funding decision-making processes was compiled, from which areas for future work or research aimed at improving the acceptability of decisions were identified. They include the explication of decision criteria and social values underpinning processes.
Similar articles
-
To fund or not to fund: development of a decision-making framework for the coverage of new health technologies.Pharmacoeconomics. 2011 Sep;29(9):771-80. doi: 10.2165/11539840-000000000-00000. Pharmacoeconomics. 2011. PMID: 21756008
-
Societal values in the allocation of healthcare resources: is it all about the health gain?Patient. 2011;4(4):207-25. doi: 10.2165/11588880-000000000-00000. Patient. 2011. PMID: 21815706 Review.
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Risk management frameworks for human health and environmental risks.J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608. J Toxicol Environ Health B Crit Rev. 2003. PMID: 14698953 Review.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
Cited by
-
Development of the WHO-INTEGRATE evidence-to-decision framework: an overview of systematic reviews of decision criteria for health decision-making.Cost Eff Resour Alloc. 2020 Feb 11;18:8. doi: 10.1186/s12962-020-0203-6. eCollection 2020. Cost Eff Resour Alloc. 2020. PMID: 32071560 Free PMC article. Review.
-
Which health technologies should be funded? A prioritization framework based explicitly on value for money.Isr J Health Policy Res. 2012 Nov 26;1(1):44. doi: 10.1186/2045-4015-1-44. Isr J Health Policy Res. 2012. PMID: 23181391 Free PMC article.
-
To fund or not to fund: development of a decision-making framework for the coverage of new health technologies.Pharmacoeconomics. 2011 Sep;29(9):771-80. doi: 10.2165/11539840-000000000-00000. Pharmacoeconomics. 2011. PMID: 21756008
-
Role of centralized review processes for making reimbursement decisions on new health technologies in Europe.Clinicoecon Outcomes Res. 2011;3:117-86. doi: 10.2147/CEOR.S14407. Epub 2011 Aug 30. Clinicoecon Outcomes Res. 2011. PMID: 22046102 Free PMC article.
-
Evaluating the quality and use of economic data in decisions about essential medicines.Bull World Health Organ. 2015 Oct 1;93(10):693-699. doi: 10.2471/BLT.14.149914. Epub 2015 Aug 14. Bull World Health Organ. 2015. PMID: 26600611 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical